An array of pharmaceutical pills with the company's logo on the bottle. Eli Lilly jumped by 14.30 percent on Thursday to end at $839.96 each as investor sentiment was buoyed by announcements that ...

Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen. Called LillyDirect, the new website is the first of its kind from a pharmaceutical company and will ...

Eli Lilly's valuation has soared over the last year given the blockbuster success of treatments such as Mounjaro and Verzenio. The company has other opportunities, including plaque psoriasis and ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and expand a program that limits out-of-pocket monthly costs for some consumers. The Indianapolis ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other other firms that ended the week strong. The stock market ended the shortened trading ...